Lyra Therapeutics, Inc. Soared
Lyra Therapeutics, Inc. (LYRA:NASDAQ) shot up at $20.25, a gain of 310.8%. On Mon, Jun 02, 2025, LYRA:NASDAQ hit a New 2-Week High of $20.25. The stock appeared on our News Catalysts scanner on Mon, Jun 02, 2025 at 11:53 AM in the 'BIOTECH' category. From Mon, May 19, 2025, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Mon, Jun 02, 2025 at $37.5 with a volume of 26M+.
About Lyra Therapeutics, Inc. (LYRA:NASDAQ)
Lyra Therapeutics Inc a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration.
Top 10 Gainers:
- Lyra Therapeutics, Inc. (LYRA:NASDAQ), 310.75%
- ModivCare Inc. (MODV:NASDAQ), 96.43%
- Brand Engagement Network, Inc. (BNAI:NASDAQ), 75.63%
- Vera Therapeutics, Inc. (VERA:NASDAQ), 67.49%
- AgEagle Aerial Systems, Inc. (UAVS:NYSEMKT), 63.27%
- Hong Kong Pharma Digital Technology Holdings Limited (HKPD:NASDAQ), 58.12%
- Clene Inc. (CLNN:NASDAQ), 53.61%
- Kymera Therapeutics, Inc. (KYMR:NASDAQ), 45.51%
- Reitar Logtech Holdings Limited (RITR:NASDAQ), 41.37%
- Hyperfine, Inc. (HYPR:NASDAQ), 41.08%